Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Thats where some of the affordability concerns are coming from: large populations are potentially eligible to take these drugs, and we cant pay for a lifetime supply for everyone. The researchers model suggested that even though the alternative weight-maintenance programs might be slightly less effective than long-term, full-dosage GLP-1RA use, the clinical benefits would only decrease slightly, while lifetime healthcare spending would decrease substantially
Diabetes Care 21 October 2024
At year 1, superior weight loss with liraglutide (7.8 kg) over both placebo (2.0 kg) and orlistat (3.9 kg) was demonstrated
Store Saxenda as directed by healthcare professionals
Association of bariatric surgery with cancer incidence in patients with obesity and diabetes: long-term results from the Swedish Obese Subjects study
These figures validate payer concerns
US$ 21.62
US$ 22.65
US$ 24.07
US$ 24.95
US$ 29.78
US$ 27.13
US$ 23.38
